T Man Pharmaceutical PCL
SET:TMAN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
T Man Pharmaceutical PCL
Total Equity
T Man Pharmaceutical PCL
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
T
|
T Man Pharmaceutical PCL
SET:TMAN
|
Total Equity
฿2.1B
|
CAGR 3-Years
27%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
M
|
Mega Lifesciences PCL
SET:MEGA
|
Total Equity
฿10.2B
|
CAGR 3-Years
5%
|
CAGR 5-Years
8%
|
CAGR 10-Years
9%
|
|
|
I
|
Inter Pharma PCL
SET:IP
|
Total Equity
฿2B
|
CAGR 3-Years
34%
|
CAGR 5-Years
35%
|
CAGR 10-Years
N/A
|
|
|
J
|
Jack Chia Industries Thailand PCL
SET:JCT
|
Total Equity
฿1.4B
|
CAGR 3-Years
3%
|
CAGR 5-Years
4%
|
CAGR 10-Years
4%
|
|
|
J
|
JSP Industrial Pharmacy (Thailand) PCL
SET:JSP
|
Total Equity
฿908.6m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
B
|
Bangkok Lab and Cosmetic PCL
SET:BLC
|
Total Equity
฿1.7B
|
CAGR 3-Years
84%
|
CAGR 5-Years
68%
|
CAGR 10-Years
N/A
|
|
T Man Pharmaceutical PCL
Glance View
T Man Pharmaceutical PCL is a TH-based company operating in industry. The company is headquartered in Bangkok, Bangkok Metropolis. The company went IPO on 2024-10-22. T.Man Pharmaceutical Public Company Limited is engaged in purchasing, importing, manufacturing, original equipment manufacturing, distributing and exporting of modern medicines, traditional medicine, dietary supplements, and health care products for the healthcare industry with subsidiaries as manufacturers. Its segments include manufactured products under own brand, manufactured products under third parties’ brand and trading products. With a diverse range of manufacturing machinery, it can produce various types of pharmaceutical products, meeting the needs of every consumer. Its production capabilities include tablets, capsules, powders, liquids, and semisolids. The company offers capsule products, including both hard and soft capsules in various sizes, all made with imported, high-quality raw materials. Its product range covers a wide range of diseases and comes in various forms, including uncoated tablets, sugar-coated tablets, film-coated tablets, enteric-coated tablets, and suppositories.
See Also
What is T Man Pharmaceutical PCL's Total Equity?
Total Equity
2.1B
THB
Based on the financial report for Dec 31, 2025, T Man Pharmaceutical PCL's Total Equity amounts to 2.1B THB.
What is T Man Pharmaceutical PCL's Total Equity growth rate?
Total Equity CAGR 3Y
27%
Over the last year, the Total Equity growth was 20%. The average annual Total Equity growth rates for T Man Pharmaceutical PCL have been 27% over the past three years .
